| Literature DB >> 28509122 |
Kunihiko Yasuda1, Takatsugu Iwashita1, Yosuke Tayama1, Yuko Makino1, Ayumu Watanabe2, Tatsuro Sano1, Taisuke Shimizu1, Tomonari Ogawa1, Koichi Kanozawa1, Hajime Hasegawa3.
Abstract
Hyponatremia presents with various central nervous system symptoms during its course and treatment. We treated a patient who presented with a prolonged consciousness disorder and was suspected of having complications of neuroleptic malignant syndrome and osmotic demyelination syndrome (ODS) during the treatment for his hyponatremia, which was caused by syndrome of inappropriate secretion of antidiuretic hormone (SIADH). The patient was a 30-year-old Japanese man who had been under treatment for schizophrenia. He presented with profound hyponatremia (96 mEq/L) and a consciousness disorder. Because he was taking a number of antipsychotic drugs and since psychogenic polydipsia was present along with laboratory findings, the patient was diagnosed with SIADH. However, the consciousness disorder reappeared after his serum sodium concentrations were normalized, and it persisted over a long period. Although ODS was suspected from the clinical course and imaging findings, there were several inconsistencies, such as the lack of quadriplegia. The patient also showed muscular rigidity and fever, and we, therefore, diagnosed complications of malignant hyperthermia syndrome caused by the discontinuation of all antipsychotic drugs at the time of onset. There have been no reports of complications of these two conditions, and we report this case for its clinically valuable information.Entities:
Keywords: Hyponatremia; Neuroleptic malignant syndrome; Osmotic demyelination syndrome; Syndrome of inappropriate secretion of antidiuretic hormone
Year: 2016 PMID: 28509122 PMCID: PMC5438799 DOI: 10.1007/s13730-016-0234-1
Source DB: PubMed Journal: CEN Case Rep ISSN: 2192-4449
Preadministered antipsychotic medications
| Administered dose | Regular dose in Japan | |
|---|---|---|
| SIADH-inducible (reported) medications | ||
| Chlorpromazine hydrochloride | 225 mg | 30–100 mg |
| Levomepromazine | 50 mg | 25–200 mg |
| Phenotiazine derivatives | 1 tablet | 1–2 tablets |
| Risperidone | 8 mg | 12 mg |
| Sodium valproate | 1000 mg | 400–1200 mg |
| SIADH-uninducible medications | ||
| Biperiden | 4 mg | 3–6 mg |
| Trihexyphenidyl hydrochloride | 6 mg | 6–10 mg |
| Alprazolam | 1.2 mg | 1.2 mg |
| Estazolam | 2 mg | 1–4 mg |
| Flunitrazepam | 2 mg | 0.5–2 mg |
| Quazepam | 15 mg | 20 mg |
Laboratory test of blood and urine
| Urinalysis | Endocrinology | ||
| Urine specific gravity | 1.011 | Adrenocorticotropic hormone (pg/mL) | 160.3 |
| Red blood cells (cells/HPF) | 1–4 | Free T4 (pg/mL) | 1.8 |
| White blood cells (cells/HPF) | 0–1 | Free T3 (pg/mL) | 2.2 |
| pH | 5.5 | Thyroid stimulating hormone (μIU/mL) | 0.2 |
| Protein | +1 | Cortisol (µg/dL) | 37.3 |
| Sugar | Negative | Aldosterone (pg/mL) | 52.7 |
| Ketone | Negative | Plasma renin activity (ng/ml/h) | 6.9 |
| Urine chemistry | Blood cell count | ||
| Creatinine (mg/dL) | 70 | White blood cells (/µL) | 13,100 |
| Urea nitrogen (mg/dL) | 271 | Hemoglobin (g/dL) | 13.8 |
| Na (mEq/L) | 53 | Platelet (/µL) | 122 × 103 |
| Cl (mEq/L) | 17 | Blood gas analysis | |
| K (mEq/L) | 37.5 | pH | 7.52 |
| Urine osmolality (mOsm/kg) | 332 | pCO2 (mmHg) | 50.0 |
| Blood biochemistry and immunology | pO2 (mmHg) | 63.5 | |
| Na (mEq/L) | 96 | HCO3 − (mmol/L) | 40.2 |
| Cl (mEq/L) | 46 | ||
| K (mEq/L) | 1.9 | ||
| Corrected calcium (mg/dL) | 8.4 | ||
| Total protein (g/dL) | 6.9 | ||
| Blood urea nitrogen (mg/dL) | 9.8 | ||
| Creatinine (mg/dL) | 0.90 | ||
| Estimated GFR (mL/min) | 82.0 | ||
| Aspartate transaminase (IU/L) | 30 | ||
| Alanine aminotransferase (IU/L) | 16 | ||
| Lactate dehydrogenase (IU/L) | 266 | ||
| Uric acid (mg/dL) | 8.6 | ||
| CRP | 0.4 | ||
| CK | 574 | ||
| Plasma osmolality (mOsm/kg) | 195 |
Fig. 1Brain MRI study (T2-weighted image) on hospital day-5 and day-54. White arrowheads indicate high-intensity signals in the ventral posterolateral nucleus (VPL)
Fig. 2Clinical course of the present case, a 30-year-old Japanese male